TREM2 and Alzheimer disease: Recent studies discovered gene variants of TREM2 as risk factors for developing AD68, and there is evidence from AD mouse models that TREM2-mediated microglial activation contributes to uptake and degradation of soluble Aβ at early stages, whereas it contributes to the formation of dense-core plaques at later stages69,70.